NYMXF Alzheimer's treatment! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NYMXF Alzheimer's treatment!

NYMXF 0.106

0.0%

Nov 3 11:17 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tommysdad who wrote (45)	3/17/1998 7:48:00 PM
From: Pseudo Biologist	Read Replies (1) of 132

Tommysdad, I also find this pretty fishy, and would stay away from it, but they do seem to have issued US patents on aspects of their technology. Try a search with "Averback" the last name of the CEO. You'll get a few hits; one that appears relevant is: patents.ibm.com A summary follows (maybe DMS became Nymox?): 5567720 : Pharmaceutically active agents that impede amyloid formation in vivo INVENTORS: Averback; Paul, Montreal, Canada ASSIGNEES: DMS Pharmaceutical Inc., Quebec, Canada ISSUED: Oct.ÿ22,ÿ1996 ABSTRACT:ÿÿ Dense microspheres can be extracted and purified to substantial homogeneity from mammalian brain tissue, and used in the screening of therapies for potential effectiveness in impeding the formation of amyloid fibrils associated with Alzheimer's disease and other forms of cerebral amyloidosis. Compounds that, at in-tissue concentrations of 10-5 M or less, inhibit amyloid formation in a test animal injected intracerebrally with dense microspheres are particularly useful in inhibiting treating cerebral amyloidosis. ************* PB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next